º¹ÒºÊÇ·ñ»á´«²¥ÒҸΣ¿

·¢²¼£º2017-09-20¡¡|¡¡À´Ô´£º²Ìð©¶«Ò½Éú×ÔýÌå¡¡|¡¡ä¯ÀÀ£º14175

½Ó´¥µ½ÒҸβ¡È˵ĺ¹Òº£¬»á²»»á¸ÐȾÒҸΣ¿

ÒҸβ¡¶¾¸ÐȾÕߵĺ¹ÒºÖÐȷʵ¿ÉÒÔ¼ì²âµ½ÒҸβ¡¶¾¡£²»½ö¹«ÖÚµ£ÐÄÒҸβ¡¶¾¸ÐȾÕߵĺ¹ÒºÊÇ·ñ»á´«²¥ÒҸΣ¬¿ÆÑ§¼ÒÃÇÒ²ÔÚ¹Ø×¢Õâ¸öÎÊÌâ¡£1980Ä꣬ÈÕ±¾Ò»ËùÏàÆË¾ãÀÖ²¿ÀïÔø·¢ÉúÒÒ¸ÎÒßÇé[1]¡£µ±Ê±µÄÒßÇ鱩·¢Ô­Òò²¢²»Ã÷È·£¬ÈËÃǵ£ÐÄÒҸβ¡¶¾¸ÐȾµÄÔ˶¯Ô±ÔÚ´óÁ¿³öº¹Ê±£¬ÌåÄڵIJ¡¶¾»á²»»á³öÏÖÔÚº¹ÒºÖУ¿Ë¤õÓÔ˶¯Ô±ÔÚ±ÈÈüʱÓÐÉíÌå¼äµÄÃÜÇнӴ¥£¬ÆÚ¼ä¿ÉÄÜ»áÊÜÉË£¬Ò»µ©½Ó´¥ÁËЯ´ø²¡¶¾µÄº¹Òº£¬»á²»»á±»¸ÐȾ£¿2007Ä꣬ÍÁ¶úÆäµÄ¿ÆÑ§¼Ò¶Ô70ÀýˤõÓÔ˶¯Ô±µÄѪҺºÍº¹Òº½øÐÐÁ˼ì²â£¬½á¹ûÔÚ9ÀýˤõÓÑ¡ÊÖµÄѪҺÄÚ¼ì²âµ½ÒҸβ¡¶¾»ùÒòDNA£¬Õâ9λѡÊÖÖÐÓÐ8ÀýµÄº¹ÒºÀï¼ì²âµ½ÒҸβ¡¶¾µÄ»ùÒò£¬µ«Ë®Æ½ºÜµÍ[2]¡£Ææ¹ÖµÄÊÇ£¬Õâ9ÀýÔ˶¯Ô±ÑªÒºµÄÒҸαíÃæ¿¹Ô­¾ùΪÒõÐÔ¡£ÕâÆªÎÄÕ·¢²¼ºóÁ¢¼´ÒýÆð¹ã·º¹Ø×¢£¬Ðí¶àÈ˵£Ðĺ¹ÒºÓд«²¥ÒҸεĿÉÄÜ¡£2012Ä꣬ÈÕ±¾µÄ¿ÆÑ§¼Ò´Ó9Àý¸ß²¡¶¾¸´ÖÆ(ѪÇåHBV DNA´óÓÚ10µÄ6´Î·½)µÄÒҸβ¡¶¾¸ÐȾÕߵĺ¹ÒºÖмì²âµ½HBV DNA£¬µ«º¹ÒºÖÐHBV DNAµÄˮƽÃ÷ÏÔµÍÓÚѪÇåHBV DNA[3]¡£Òò´Ë¿ÉÒÔÈ·¶¨£¬ÒҸβ¡¶¾¸ÐȾÕߵĺ¹ÒºÖÐÊÇ¿ÉÒÔ¼ì²âµ½ÒҸβ¡¶¾µÄ¡£

µ«ÊÇ£¬¼ì²âµ½²¡¶¾²¢²»µÈÓÚ²¡¶¾Äܹ»´«²¥¡£ÌåÒºÖеijɷÖÓëѪҺÏà²î½Ï´ó£¬ÔÚ²»ÀûÓÚ²¡¶¾´æ»îµÄÌõ¼þÏ£¬²¡¶¾»áºÜ¿ìËÀÍö²¢Ê§È¥¸ÐȾÄÜÁ¦¡£ÀýÈ磬ÔÚÒҸβ¡¶¾¸ÐȾÕߵĴó±ãÖÐÊÇ¿ÉÒÔ¼ì²âµ½ÒҸβ¡¶¾µÄ£¬µ«ÒҸβ¡¶¾²¢²»ÄÜÏñ¼×Ð͸ÎÑ×ÄÇÑùͨ¹ý¡°·à¡ª¿Ú;¾¶¡±´«²¥¡£ÓпÆÑ§¼Ò¶Ô33Àý¶ùͯºÍ17Àý³ÉÈËÒҸβ¡¶¾¸ÐȾÕߵĴó±ã½øÐв¡¶¾¼ì²â£¬74%µÄ´ó±ãÖмì²âµ½HBV DNA¡£µ«ÊÇ£¬ÓÃÕâЩЯ´ø²¡¶¾µÄ·à±ã½øÐж¯ÎïÊÔÑ飬ÎÞÂÛÊǿڷþ»¹ÊǾ²Âö×¢É䣬¶¼Ã»ÓгöÏÖ¸ÐȾ[4]¡£Òò´Ë£¬Ñо¿ÕßÈÏΪÒҸβ¡¶¾¸ÐȾÕß´ó±ãÖеIJ¡¶¾ÒѾ­Ê§È¥¸ÐȾÈËÌåµÄÄÜÁ¦¡£¾¡¹ÜĿǰûÓмìË÷µ½ÀàËÆµÄÓйغ¹ÒºµÄÊÔÑ飬µ«ÊÇ·ÖÎöº¹ÒºÖеijɷֿÉÒÔ·¢ÏÖ£¬ÆäÂÈ»¯Äƺ¬Á¿ºÜ¸ß£¬Ô¼Îª300ºÁ¿Ë/100ºÁÉý£¬Õâô¸ßµÄÉøÍ¸Ñ¹²¡¶¾ºÜÄÑ´æ»î¡£

ΪÁËÃ÷ȷˤõÓÔ˶¯Ô±ÓÐûÓиÐȾÒҸεķçÏÕ£¬ÒÁÀÊÔ˶¯Ò½Ñ§Ñо¿ÖÐÐĶÔ420ÀýˤõÓÔ˶¯Ô±½øÐÐÁËÓйØÒÒÐ͸ÎÑ×Á÷Ðв¡Ñ§·½ÃæµÄÑо¿[5]¡£½á¹û·¢ÏÖ£¬Ë¤õÓÔ˶¯Ô±¸ÐȾÒҸβ¡¶¾µÄ·çÏÕÓë¶ÔÕÕ×éÎÞÃ÷ÏÔÇø±ð¡£Ñо¿ÈËÔ±ÓÖ¶ÔÒҸβ¡¶¾¸ÐȾµÄÔ˶¯Ô±½øÐÐÁ˵÷²é£¬½á¹û·¢ÏÖÕâЩÔ˶¯Ô±¸ÐȾÒҸβ¡¶¾µÄ·çÏÕÒòËØÒ²Óë¶ÔÕÕ×éÒ»Ñù£¬Ö÷ÒªÊÇΣÏÕÐÔÐÐΪ¡¢¹²ÓÃÌÞÐëµ¶¡¢ÊÖÊõ¼°Íâ¿ÆÖÎÁÆ¡£Õâ˵Ã÷ˤõÓÔ˶¯Ô±¸ÐȾÒҸβ¡¶¾µÄ·çÏÕÓëËûÃǵÄÖ°Òµ£¨³öº¹¼°ÉíÌå½Ó´¥£©ÎÞÃ÷ÏÔÏà¹ØÐÔ¡£

×ܽáÉÏÊöÄÚÈÝ£¬ÒҸβ¡¶¾¸ÐȾÕߵĺ¹ÒºÖпÉÒÔ¼ì²âµ½ÒҸβ¡¶¾µÄ»ùÒò£¬µ«Ë®Æ½ºÜµÍ£¬ÓÐûÓд«È¾ÐÔÉв»Ã÷È·£¬¼´Ê¹Óд«È¾ÐÔ£¬Æ¤·ô±íÃæÃ»ÓÐÐÂÏÊÆÆËðµÄÉË¿ÚÒ²²»»á·¢Éú¸ÐȾ¡£ºó²¹³äÖØÒªµÄÒ»µã£º´ó¶àÊýÃâÒß¹¦ÄÜÕý³£µÄ³ÉÄêÈËÊÇ¿ÉÒÔµÖÓùÒҸβ¡¶¾µÄ£¬¶øÇÒÒÒ¸ÎÒ²ÊÇÒ»ÖÖ¿ÉÒÔÓÃÒßÃçÔ¤·ÀµÄ´«È¾²¡£¬ÈÝÒ×½Ó´¥µ½º¹ÒºµÄÔ˶¯Ô±»òÒҸβ¡¶¾¸ÐȾÕßµÄÇ×Êô¿ÉÒÔͨ¹ý½ÓÖÖÒÒ¸ÎÒßÃçÀ´Ô¤·À£¬²»±ØÎª½Ó´¥µ½Ò»µãº¹Òº¶ø¿Ö»Å¡£

²Î¿¼ÎÄÏ×£º

[1] Kashiwagi S, Hayashi J, Ikematsu H, Nishigori S, Ishihara K, Kaji M. An outbreak of hepatitis B in members of a high school sumo wrestling club. JAMA. 1982. 248(2): 213-4.

[2] Bereket-Yucel S. Risk of hepatitis B infections in Olympic wrestling. Br J Sports Med. 2007. 41(5): 306-10; discussion 310.

[3] Komatsu H, Inui A, Sogo T, Tateno A, Shimokawa R, Fujisawa T. Tears from children with chronic hepatitis B virus (HBV) infection are infectious vehicles of HBV transmission: experimental transmission of HBV by tears, using mice with chimeric human livers. J Infect Dis. 2012. 206(4): 478-85.

[4] Komatsu H, Inui A, Murano T, Tsunoda T, Sogo T, Fujisawa T. Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice. BMC Res Notes. 2015. 8: 366.

[5] Kordi R, Neal K, Pourfathollah AA, Mansournia MA, Wallace WA. Risk of hepatitis B and C infections in Tehranian wrestlers. J Athl Train. 2011. 46(4): 445-50.

Ïà¹ØÐÂÎÅ


×ʸñÖ¤Êé±àºÅ£º(Ãö)-·Ç¾­ÓªÐÔ-2014-0006 2015 ¸£½¨ÒÚ²©µç¾ºµç¾º¹É·ÝÓÐÏÞ¹«Ë¾ ÃöICP±¸11026770ºÅ

Ãö¹«Íø°²±¸ 35092602000113ºÅ

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿